Monocyte-to-macrophage switch reversibly impaired by Ibrutinib

Ibrutinib is increasingly adopted for treating lymphoid malignancies. While growing amounts of data pile up about Ibrutinib mechanism of action on neoplastic B cells, little is known about its impact on other immune cells. Here we investigated the effect of Ibrutinib on monocyte/macrophage functions...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrarini, Isacco, Rigo, Antonella, Montresor, Alessio, Laudanna, Carlo, Vinante, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443008/
https://www.ncbi.nlm.nih.gov/pubmed/30956776
http://dx.doi.org/10.18632/oncotarget.26744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443008/
https://www.ncbi.nlm.nih.gov/pubmed/30956776
http://dx.doi.org/10.18632/oncotarget.26744

Ejemplares similares